NovaBay Pharmaceuticals Announces Strategic Marketing Agreement for NeutroPhase in China – Yahoo Finance

EMERYVILLE, Calif., Jan. 9, 2012 (GLOBE NEWSWIRE) — NovaBay (R) Pharmaceuticals, Inc. (NYSE AMEX:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide (R) compounds for the local non-systemic …